Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy

Pattyn, S.R.; Husser, J.A.; Saint-André, P.

Acta Leprologica 4(4): 445-446

1986


ISSN/ISBN: 0001-5938
PMID: 3296614
Document Number: 268852
Ten patients infected with mouse proven DDS-resistant bacilli were treated with the following combined regimen: RMP 600 2/7 6 months, ETH 500 7/7 6 months and DDS 100 7/7 12 months. Follow up was for 27-54 months, without relapses. Added to patients from previous study (Int. J. Lepr. 1984, 52, 297-303) the 95% confidence limit decreases from 12 to 9%.

Document emailed within 1 workday
Secure & encrypted payments